{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:16:03Z","timestamp":1790018163876,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":364,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2018]]},"DOI":"10.6061\/clinics\/2018\/e551s","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T09:51:58Z","timestamp":1539683518000},"page":"e551s","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S1","title":["Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases"],"prefix":"10.1016","volume":"73","author":[{"given":"Suellen","family":"Herbster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andressa","family":"Paladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumara","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Boccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.6061\/clinics\/2018\/e551s_bib1","doi-asserted-by":"crossref","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","author":"Doorbar","year":"2012","journal-title":"Vaccine"},{"key":"10.6061\/clinics\/2018\/e551s_bib2","author":"International Agency for Research on Cancer"},{"key":"10.6061\/clinics\/2018\/e551s_bib3","author":"International Agency for Research on Cancer"},{"issue":"Suppl 1","key":"10.6061\/clinics\/2018\/e551s_bib5","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ypmed.2011.08.017","article-title":"Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies","volume":"53","author":"Tota","year":"2011","journal-title":"Prev Med"},{"issue":"1","key":"10.6061\/clinics\/2018\/e551s_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bpobgyn.2017.08.006","article-title":"Epidemiology and burden of HPV-related disease","volume":"47","author":"Serrano","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"23","key":"10.6061\/clinics\/2018\/e551s_bib7","doi-asserted-by":"crossref","first-page":"12513","DOI":"10.1073\/pnas.97.23.12513","article-title":"Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways","volume":"97","author":"Goodwin","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.6061\/clinics\/2018\/e551s_bib8","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.1074\/jbc.M110.197574","article-title":"Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes","volume":"286","author":"Banerjee","year":"2011","journal-title":"J Biol Chem"},{"issue":"4893","key":"10.6061\/clinics\/2018\/e551s_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.2537532","article-title":"The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product","volume":"243","author":"Dyson","year":"1989","journal-title":"Science"},{"issue":"1","key":"10.6061\/clinics\/2018\/e551s_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/j.1460-2075.1990.tb08091.x","article-title":"The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation","volume":"9","author":"Barbosa","year":"1990","journal-title":"EMBO J"},{"issue":"6569","key":"10.6061\/clinics\/2018\/e551s_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/380079a0","article-title":"Telomerase activation by the E6 gene product of human papillomavirus type 16","volume":"380","author":"Klingelhutz","year":"1996","journal-title":"Nature"},{"issue":"9","key":"10.6061\/clinics\/2018\/e551s_bib12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/emboj\/18.9.2449","article-title":"The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth","volume":"18","author":"Brehm","year":"1999","journal-title":"EMBO J"},{"issue":"18","key":"10.6061\/clinics\/2018\/e551s_bib13","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1093\/emboj\/18.18.5061","article-title":"The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300","volume":"18","author":"Patel","year":"1999","journal-title":"EMBO J"},{"issue":"15","key":"10.6061\/clinics\/2018\/e551s_bib14","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1128\/JVI.75.15.6737-6747.2001","article-title":"Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes","volume":"75","author":"Helt","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e551s_bib15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3349\/ymj.2002.43.6.722","article-title":"Alteration of cell cycle in cervical tumor associated with human papillomavirus: cyclin-dependent kinase inhibitors","volume":"43","author":"Cho","year":"2002","journal-title":"Yonsei Med J"},{"issue":"7","key":"10.6061\/clinics\/2018\/e551s_bib16","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1128\/JVI.78.7.3533-3541.2004","article-title":"The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31","volume":"78","author":"Longworth","year":"2004","journal-title":"J Virol"},{"issue":"6-7","key":"10.6061\/clinics\/2018\/e551s_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0463.2010.02618.x","article-title":"Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses","volume":"118","author":"Pim","year":"2010","journal-title":"APMIS"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0092-8674(91)90529-8","article-title":"Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation","volume":"67","author":"Crook","year":"1991","journal-title":"Cell"},{"issue":"8","key":"10.6061\/clinics\/2018\/e551s_bib19","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/j.1460-2075.1992.tb05375.x","article-title":"Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription","volume":"11","author":"Lechner","year":"1992","journal-title":"EMBO J"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell"},{"issue":"6","key":"10.6061\/clinics\/2018\/e551s_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"10.6061\/clinics\/2018\/e551s_bib22","first-page":"6537","article-title":"Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer","volume":"63","author":"Sheu","year":"2003","journal-title":"Cancer Res"},{"issue":"2","key":"10.6061\/clinics\/2018\/e551s_bib23","first-page":"199","article-title":"Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix","volume":"26","author":"Nasr","year":"2005","journal-title":"Eur J Gynaecol Oncol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e551s_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/gyno.2001.6413","article-title":"MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation\u2014an immunohistochemical study","volume":"84","author":"Brummer","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.6061\/clinics\/2018\/e551s_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2B","key":"10.6061\/clinics\/2018\/e551s_bib26","first-page":"1543","article-title":"Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN","volume":"26","author":"Branca","year":"2006","journal-title":"Anticancer Res"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033585","article-title":"HPV16 oncoproteins induce MMPs\/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis","volume":"7","author":"Cardeal","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.6061\/clinics\/2018\/e551s_bib28","first-page":"735","article-title":"Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix","volume":"21","author":"Zhou","year":"2002","journal-title":"Ai Zheng"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/gyno.1998.5285","article-title":"Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization","volume":"72","author":"Davidson","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.6061\/clinics\/2018\/e551s_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1749-6632.2009.04898.x","article-title":"Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia","volume":"1171","author":"No","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.6061\/clinics\/2018\/e551s_bib31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1158\/1055-9965.EPI-15-0420","article-title":"MMP-9\/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis","volume":"24","author":"Discacciati","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.6061\/clinics\/2018\/e551s_bib32","first-page":"674","article-title":"Co-expression of metalloproteinases 11 and 12 in cervical scrapes cells from cervical precursor lesions","volume":"4","author":"Valdivia","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"issue":"35","key":"10.6061\/clinics\/2018\/e551s_bib33","doi-asserted-by":"crossref","first-page":"20337","DOI":"10.1074\/jbc.270.35.20337","article-title":"Structure and promoter characterization of the human stromelysin-3 gene","volume":"270","author":"Anglard","year":"1995","journal-title":"J Biol Chem"},{"issue":"5-6","key":"10.6061\/clinics\/2018\/e551s_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1387\/ijdb.041811af","article-title":"Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies","volume":"48","author":"Folgueras","year":"2004","journal-title":"Int J Dev Biol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e551s_bib35","first-page":"265","article-title":"Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling","volume":"27","author":"Branca","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.6061\/clinics\/2018\/e551s_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03032402","article-title":"Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia","volume":"11","author":"Sobel","year":"2005","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"10.6061\/clinics\/2018\/e551s_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00384-001-0369-0","article-title":"The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma","volume":"17","author":"Zbar","year":"2002","journal-title":"Int J Colorectal Dis"},{"issue":"7","key":"10.6061\/clinics\/2018\/e551s_bib38","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"issue":"6","key":"10.6061\/clinics\/2018\/e551s_bib39","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.AOG.0000245786.86267.80","article-title":"Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer","volume":"108","author":"Hampl","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib40","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/00016340903555990","article-title":"Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma","volume":"89","author":"M\u00e4\u00e4tt\u00e4","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.6061\/clinics\/2018\/e551s_bib41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.6061\/clinics\/2018\/e551s_bib42","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","article-title":"Tumors as organs: complex tissues that interface with the entire organism","volume":"18","author":"Egeblad","year":"2010","journal-title":"Dev Cell"},{"issue":"10","key":"10.6061\/clinics\/2018\/e551s_bib43","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003202","article-title":"Cell-matrix interactions in mammary gland development and breast cancer","volume":"2","author":"Muschler","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"10.6061\/clinics\/2018\/e551s_bib44","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ceb.2004.07.010","article-title":"Regulation of matrix biology by matrix metalloproteinases","volume":"16","author":"Mott","year":"2004","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"10.6061\/clinics\/2018\/e551s_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"issue":"5564","key":"10.6061\/clinics\/2018\/e551s_bib46","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"issue":"2-3","key":"10.6061\/clinics\/2018\/e551s_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1023047431869","article-title":"Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials","volume":"22","author":"Pavlaki","year":"2003","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"10.6061\/clinics\/2018\/e551s_bib48","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1200\/JCO.2000.18.5.1135","article-title":"Matrix metalloproteinases: biologic activity and clinical implications","volume":"18","author":"Nelson","year":"2000","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.6061\/clinics\/2018\/e551s_bib49","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1517\/13543784.9.12.2913","article-title":"Marimastat: the clinical development of a matrix metalloproteinase inhibitor","volume":"9","author":"Steward","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"10.6061\/clinics\/2018\/e551s_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcdb.2007.06.006","article-title":"MMPs as therapeutic targets\u2013still a viable option?","volume":"19","author":"Fingleton","year":"2008","journal-title":"Semin Cell Dev Biol"},{"issue":"5","key":"10.6061\/clinics\/2018\/e551s_bib51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/17460441.2011.560936","article-title":"New opportunities in drug design of metalloproteinase inhibitors: combination between structure-function experimental approaches and systems biology","volume":"6","author":"Sela-Passwell","year":"2011","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"10.6061\/clinics\/2018\/e551s_bib52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tips.2013.02.004","article-title":"Missing the target: matrix metalloproteinase antitargets in inflammation and cancer","volume":"34","author":"Dufour","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"10.6061\/clinics\/2018\/e551s_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1139\/o06-084","article-title":"Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence","volume":"84","author":"da Silva Cardeal","year":"2006","journal-title":"Biochem Cell Biol"},{"issue":"8","key":"10.6061\/clinics\/2018\/e551s_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071611","article-title":"HPV16 oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases","volume":"8","author":"Kaewprag","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.6061\/clinics\/2018\/e551s_bib55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1097-0215(19960117)65:2<209::AID-IJC14>3.0.CO;2-8","article-title":"High level of MT-MMP expression is associated with invasiveness of cervical cancer cells","volume":"65","author":"Gilles","year":"1996","journal-title":"Int J Cancer"},{"key":"10.6061\/clinics\/2018\/e551s_bib56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2407-5-68","article-title":"Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer","volume":"5","author":"Vazquez-Ortiz","year":"2005","journal-title":"BMC Cancer"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib57","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/ijgc-00009577-200605000-00052","article-title":"Matrix metalloproteinases-2 and -9 in cervical cancer: different roles in tumor progression","volume":"16","author":"Rauvala","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.6061\/clinics\/2018\/e551s_bib58","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3892\/ijo_00000215","article-title":"Uterine cervical carcinoma: role of matrix metalloproteinases (review)","volume":"34","author":"Libra","year":"2009","journal-title":"Int J Oncol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib59","first-page":"565","article-title":"Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells","volume":"9","author":"Kato","year":"2002","journal-title":"Oncol Rep"},{"issue":"2","key":"10.6061\/clinics\/2018\/e551s_bib60","first-page":"93","article-title":"Membrane-associated MMP-2 in human cervical cancer","volume":"22","author":"Mitra","year":"2003","journal-title":"J Environ Pathol Toxicol Oncol"},{"issue":"6-7","key":"10.6061\/clinics\/2018\/e551s_bib61","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.biocel.2007.12.006","article-title":"The regulation of matrix metalloproteinases and their inhibitors","volume":"40","author":"Clark","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"issue":"Pt 5","key":"10.6061\/clinics\/2018\/e551s_bib62","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1099\/vir.0.80551-0","article-title":"Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products","volume":"86","author":"Smola-Hess","year":"2005","journal-title":"J Gen Virol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib63","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ygyno.2007.11.018","article-title":"Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array","volume":"108","author":"Wang","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.6061\/clinics\/2018\/e551s_bib64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijgo.2005.08.021","article-title":"Matrix metalloproteinase 9 in the uterine cervix during tumor progression","volume":"92","author":"Talvensaari-Mattila","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"10.6061\/clinics\/2018\/e551s_bib65","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1007\/s13277-014-1990-1","article-title":"ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma","volume":"35","author":"Xu","year":"2014","journal-title":"Tumour Biol"},{"issue":"5","key":"10.6061\/clinics\/2018\/e551s_bib66","first-page":"539","article-title":"Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells","volume":"36","author":"Xu","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib67","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/gyno.1995.1154","article-title":"Basement membranes in cervical cancer: relationship to pelvic lymph node metastasis and prognosis","volume":"57","author":"Bremer","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.6061\/clinics\/2018\/e551s_bib68","first-page":"380","article-title":"Prognostic significance of topoisomerase II alpha and collagen IV immunoexpression in cervical cancer","volume":"31","author":"Smrkolj","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.6061\/clinics\/2018\/e551s_bib69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13148-016-0290-6","article-title":"In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion","volume":"8","author":"Thangavelu","year":"2016","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10.6061\/clinics\/2018\/e551s_bib70","first-page":"39","article-title":"Syndecan-1 expression in cancer of the uterine cervix: association with lymph node metastasis","volume":"20","author":"Numa","year":"2002","journal-title":"Int J Oncol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib71","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ygyno.2004.11.004","article-title":"Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer","volume":"96","author":"Shinyo","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3802\/jgo.2011.22.3.161","article-title":"Prognostic significance of syndecan-1 expression in cervical cancers","volume":"22","author":"Kim","year":"2011","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e551s_bib73","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.humpath.2004.12.001","article-title":"Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma","volume":"36","author":"Sobel","year":"2005","journal-title":"Hum Pathol"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib74","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W","article-title":"Expression of the 67 KD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: an immunohistochemical study","volume":"181","author":"al-Saleh","year":"1997","journal-title":"J Pathol"},{"issue":"12","key":"10.6061\/clinics\/2018\/e551s_bib75","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/modpathol.2010.154","article-title":"Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer","volume":"23","author":"Gorter","year":"2010","journal-title":"Mod Pathol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e551s_bib76","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1111\/j.1525-1438.2006.00741.x","article-title":"Increased expression of galectin-1 during the progression of cervical neoplasia","volume":"16","author":"Kohrenhagen","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.6061\/clinics\/2018\/e551s_bib77","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ijrobp.2013.08.037","article-title":"Galectin-1 is an independent prognostic factor for local recurrence and survival after definitive radiation therapy for patients with squamous cell carcinoma of the uterine cervix","volume":"87","author":"Huang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.6061\/clinics\/2018\/e551s_bib78","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12885-015-1272-3","article-title":"Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression","volume":"15","author":"Full\u00e1r","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"10.6061\/clinics\/2018\/e551s_bib79","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ygyno.2005.09.019","article-title":"Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes","volume":"100","author":"F\u00fcle","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.6061\/clinics\/2018\/e551s_bib80","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2133.2003.05028.x","article-title":"Hyaluronan, CD44 and versican in epidermal keratinocyte tumours","volume":"148","author":"Karvinen","year":"2003","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e551s_bib81","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1365-2133.2009.09031.x","article-title":"Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7","volume":"160","author":"Hartmann-Petersen","year":"2009","journal-title":"Br J Dermatol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222011437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222011437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:02:06Z","timestamp":1761721326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222011437"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322018000200321&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/alterations-in-the-expression-and-activity-of-extracellular-matrix-components-in-hpv-associated-infections-and-diseases\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":80,"alternative-id":["S1807593222011437"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2018\/e551s","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2018\/e551s","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e551s"}}